DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Peroxisome Proliferator Activated Receptor Delta, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peroxisome Proliferator Activated Receptor Delta and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Mentioned:
- Chipscreen Biosciences Ltd
- Connexios Life Sciences Pvt. Ltd.
- CymaBay Therapeutics, Inc.
- Daiichi Sankyo Company, Limited
- Genfit SA
- GlaxoSmithKline Plc
- Inventiva
- Mitobridge, Inc.
- Nippon Chemiphar Co., Ltd.
- T3D Therapeutics, Inc.
- vTv Therapeutics Inc
Key Topics Covered:
- Introduction
- Peroxisome Proliferator Activated Receptor Delta Overview
- Therapeutics Development
- Pipeline Products for Peroxisome Proliferator Activated Receptor Delta - Overview
- Pipeline Products for Peroxisome Proliferator Activated Receptor Delta - Comparative Analysis
- Peroxisome Proliferator Activated Receptor Delta - Therapeutics under Development by Companies
- Peroxisome Proliferator Activated Receptor Delta - Therapeutics under Investigation by Universities/Institutes
- Peroxisome Proliferator Activated Receptor Delta - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Peroxisome Proliferator Activated Receptor Delta - Products under Development by Companies
- Peroxisome Proliferator Activated Receptor Delta - Products under Investigation by Universities/Institutes
- Peroxisome Proliferator Activated Receptor Delta - Companies Involved in Therapeutics Development
For more information about this report visit http://www.researchandmarkets.com/research/p4qr6d/peroxisome
